These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12381197)

  • 21. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dynamics force probe simulations of antibody/antigen unbinding: entropic control and nonadditivity of unbinding forces.
    Heymann B; Grubmüller H
    Biophys J; 2001 Sep; 81(3):1295-313. PubMed ID: 11509346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten.
    Sotriffer CA; Rode BM; Varga JM; Liedl KR
    Biophys J; 2000 Aug; 79(2):614-28. PubMed ID: 10919996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity.
    Buchbinder JL; Stephenson RC; Scanlan TS; Fletterick RJ
    J Mol Biol; 1998 Oct; 282(5):1033-41. PubMed ID: 9753552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the origin of altered diastereomeric ratios for anionic versus neutral reaction conditions in the oxy-Cope/ene reaction: an interplay of experiment and computational modeling.
    Hooper J; Sauer EL; Arns S; Woo TK; Barriault L
    Chemistry; 2010 Dec; 16(47):14124-30. PubMed ID: 20957622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restricted diversity of antigen binding residues of antibodies revealed by computational alanine scanning of 227 antibody-antigen complexes.
    Robin G; Sato Y; Desplancq D; Rochel N; Weiss E; Martineau P
    J Mol Biol; 2014 Nov; 426(22):3729-3743. PubMed ID: 25174334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic haptens as probes of antibody response and immunorecognition.
    Shreder K
    Methods; 2000 Mar; 20(3):372-9. PubMed ID: 10694458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.
    Archontis G; Simonson T; Karplus M
    J Mol Biol; 2001 Feb; 306(2):307-27. PubMed ID: 11237602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of the exo and endo pathways of the Diels-Alder reaction by antibody catalysis.
    Gouverneur VE; Houk KN; de Pascual-Teresa B; Beno B; Janda KD; Lerner RA
    Science; 1993 Oct; 262(5131):204-8. PubMed ID: 8211138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the generation of catalytic antibodies by transition state analogues.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J; Warshel A
    Chembiochem; 2003 Apr; 4(4):277-85. PubMed ID: 12672107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives.
    Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J
    Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electronic structure, binding energy, and solvation structure of the streptavidin-biotin supramolecular complex: ONIOM and 3D-RISM study.
    Li Q; Gusarov S; Evoy S; Kovalenko A
    J Phys Chem B; 2009 Jul; 113(29):9958-67. PubMed ID: 19545155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template.
    Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA
    Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of histidine-85 in the catalytic mechanism of thymidine phosphorylase as assessed by targeted molecular dynamics simulations and quantum mechanical calculations.
    Mendieta J; Martín-Santamaría S; Priego EM; Balzarini J; Camarasa MJ; Pérez-Pérez MJ; Gago F
    Biochemistry; 2004 Jan; 43(2):405-14. PubMed ID: 14717594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular forces in antibody maturation.
    Demirel MC; Lesk AM
    Phys Rev Lett; 2005 Nov; 95(20):208106. PubMed ID: 16384106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G protein inactive and active forms investigated by simulation methods.
    Khafizov K; Lattanzi G; Carloni P
    Proteins; 2009 Jun; 75(4):919-30. PubMed ID: 19089952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular dynamics study of the stability of staphylococcal nuclease mutants: component analysis of the free energy difference of denaturation.
    Yamaotsu N; Moriguchi I; Kollman PA; Hirono S
    Biochim Biophys Acta; 1993 Apr; 1163(1):81-8. PubMed ID: 8476933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.